Tag: Select Agents

An international research team has developed a mathematical model for monitoring and controlling the spread of melioidosis in Southeast Asia. ...

A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of ...

Soligenix, Inc. announced on July 9 that it has received notice of allowance for European and Canadian patent applications further ...

The phylogenetic tree of the Ebola epidemic of 2013-2016 doesn’t just tell us how the Ebola virus was able to ...

AntoXa Corporation has obtained a license from Defence Research & Development Canada (DRDC), an Agency of the Canadian Department of ...

The House Appropriations Subcommittee on Labor, Health and Human Services, and Education held an oversight hearing focused on the FY2019 ...

Unprecedented levels of immunosuppression in countries like Australia and the US must be considered in planning for the risk of ...

Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers ...

A modeling study published last month in the Proceedings of the National Academies of Science suggests that human fleas and ...

Concept drawing of vaccinia. Credit: Shutterstock Bavarian Nordic announced on Feb. 6 the results of a successful Phase 3 clinical ...

General Atomics Electromagnetic Systems (GA-EMS) has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop ...

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T), in collaboration with the Office of Health Affairs National Biosurveillance Integration ...

The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of ...

Researchers from the University of Copenhagen and Phillips Universität Marburg have found a new target for inhibiting Ebola virus from ...

The Biomedical Advanced Research and Development Authority (BARDA) has awarded funding to Tangen BioSciences for advanced development of the company’s ...

The recent outbreak of pneumonic plague in Madagascar presents a test case as to how well the international community has ...

Elusys Therapeutics, Inc. announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatment for ...

Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...

At left, principal investigator Jean Challacombe, assisted by Cheryl Gleasner, work on sequencing the Francisella genomes at Los Alamos. The ...

Two Johns Hopkins materials science graduate students and their professors played a key role in a multi-institution research project that ...